1. Home
  2. CCK vs RDY Comparison

CCK vs RDY Comparison

Compare CCK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCK
  • RDY
  • Stock Information
  • Founded
  • CCK 1906
  • RDY 1984
  • Country
  • CCK United States
  • RDY India
  • Employees
  • CCK N/A
  • RDY N/A
  • Industry
  • CCK Containers/Packaging
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCK Industrials
  • RDY Health Care
  • Exchange
  • CCK Nasdaq
  • RDY Nasdaq
  • Market Cap
  • CCK 11.3B
  • RDY 13.1B
  • IPO Year
  • CCK N/A
  • RDY N/A
  • Fundamental
  • Price
  • CCK $89.82
  • RDY $14.17
  • Analyst Decision
  • CCK Buy
  • RDY Buy
  • Analyst Count
  • CCK 13
  • RDY 1
  • Target Price
  • CCK $105.83
  • RDY $17.00
  • AVG Volume (30 Days)
  • CCK 1.0M
  • RDY 697.0K
  • Earning Date
  • CCK 10-17-2024
  • RDY 11-05-2024
  • Dividend Yield
  • CCK 1.11%
  • RDY 6.76%
  • EPS Growth
  • CCK N/A
  • RDY 4.63
  • EPS
  • CCK 0.82
  • RDY 0.76
  • Revenue
  • CCK $11,756,000,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • CCK N/A
  • RDY $13.39
  • Revenue Next Year
  • CCK $3.12
  • RDY $8.35
  • P/E Ratio
  • CCK $109.68
  • RDY $19.00
  • Revenue Growth
  • CCK N/A
  • RDY 12.37
  • 52 Week Low
  • CCK $69.61
  • RDY $12.90
  • 52 Week High
  • CCK $98.46
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • CCK 34.99
  • RDY 30.39
  • Support Level
  • CCK $92.40
  • RDY $14.99
  • Resistance Level
  • CCK $94.92
  • RDY $15.19
  • Average True Range (ATR)
  • CCK 1.88
  • RDY 0.28
  • MACD
  • CCK -0.54
  • RDY -0.07
  • Stochastic Oscillator
  • CCK 6.82
  • RDY 11.43

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: